Effect of DHA Supplements on Macular Function in Patients With Stargardt Macular Dystrophy and Stargardt-like Macular Dystrophy
PHASE1CompletedINTERVENTIONAL
Enrollment
22
Participants
Timeline
Start Date
May 5, 2003
Study Completion Date
December 10, 2007
Conditions
Macular Degeneration
Interventions
DRUG
Docosahexaenoic Acid (DHA) Dietary Supplement
Trial Locations (1)
20892
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda
All Listed Sponsors
lead
National Eye Institute (NEI)
NIH
NCT00060749 - Effect of DHA Supplements on Macular Function in Patients With Stargardt Macular Dystrophy and Stargardt-like Macular Dystrophy | Biotech Hunter | Biotech Hunter